Mounjaro thyroid cancer risk

It seems there might be a misunderstanding with your request. If you are referring to the medication "Mounjaro" (tirzepatide), used for managing diabetes, and its potential risk of thyroid cancer, please let me know so I can provide accurate information based on relevant experts.

Mounjaro, similar to other weight loss medications, has several side effects. These include:

• Nausea: A significant number of users experience nausea. About 25% report feeling nauseated, especially within the first five months of usage 1.
• Gastrointestinal Issues: Common GI problems include diarrhea and constipation. On the highest dose, one-third of users suffer from nausea, and some experience vomiting, especially after consuming rich or fried foods 1.

These short-term side effects can be quite bothersome, but they often improve over time as users adjust to the medication.

The recommended dosage for Mounjaro starts at 2.5 mg per week. This is to ensure users acclimate to the medication and minimize side effects. Over time, the dosage can be gradually increased based on individual needs and responses, potentially up to 15 mg weekly. It's crucial to follow a healthcare provider's guidance during this process to avoid complications 1.